Phase 4 ADHD Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- Children of any gender, race, ethnicity, or socioeconomic background
- Children currently aged between 8 years 0 months and 12 years, 11 months, and 30 days old
- Children who are willing to answer questions about ADHD and related conditions
- Children with ADHD who are willing to temporarily stop taking prescribed stimulant medications as directed by the study procedures
- Children with ADHD who are willing to take part in a single-dose study that looks at how a medication called methylphenidate affects certain biological markers in the body
- Children who are predominantly right-handed
- Children who are able to take part in and sign an informed consent form
- Children with ADHD whose diagnosis meets recognised medical guidelines (DSM-5), which may include a condition called Oppositional Defiant Disorder
- Healthy children (without ADHD) who have no ADHD or other developmental or psychiatric conditions, based on recognised medical guidelines (DSM-5)
Who may not be able to join:
- Children who have been diagnosed with intellectual disability, cerebral palsy, Autism Spectrum Disorder, traumatic brain injury, brain tumour, epilepsy, or another serious neurological condition
- Children who have been diagnosed with Major Depression, Bipolar Disorder, Conduct Disorder, Adjustment Disorder, an anxiety disorder, or another developmental psychiatric condition
- Girls who have begun their menstrual period, or who are pregnant
- Children currently taking antidepressants, non-stimulant ADHD medications, dopamine-blocking medications, or mood-stabilising medications
- Children who have an implanted medical device, such as a brain stimulator, vagal nerve stimulator, a shunt in the brain, a cardiac pacemaker, or an implanted medication port
- Children who have been diagnosed with a speech or language disorder, or a reading disability
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Donald L Gilbert, MD, Children's Hospital Medical Center, Cincinnati
Phone: 800-344-2462
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Transcranial Magnetic Stimulation (TMS)-evoked Short Interval Cortical Inhibition (SICI) Test-Retest Reliability; Transcranial Magnetic Stimulation (TMS)-evoked Task Related Up Modulation (TRUM) Test-Retest Reliability
Can't join this trial?
Data last synced from ClinicalTrials.gov: 21 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.